NCT00627445View on ClinicalTrials.gov

Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

441

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

biphasic insulin aspart 30

Treat-to-target dose titration scheme (dose adjusted individually), s.c. (under the skin) injection before dinner

DRUG

metformin

Tablets, 500 - 2000 mg, once, twice or three times daily

DRUG

biphasic insulin aspart 50

Treat-to-target dose titration scheme (dose adjusted individually), s.c. (under the skin) injection before breakfast and lunch

Trial Locations (1)

100034

Beijing

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY